INM · InMed Pharmaceuticals Inc.
$1.51
+0.05 (+3.42%)
At close · Aug 4
Going-concern doubt
— flagged May 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has concluded that there is substantial doubt about its ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. management has determined that the Company's liquidity condition raises substantial doubt about the Company's ability to continue as a going concern, which is considered to be for a period of one year from the issuance of these financial statements.”View the 10-Q filed May 6, 2026
Market Cap
$4.84M
Shares
3.31M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-07 | 1,050 | $1.61 | $1,691 |
| 2026-07-01 | 63 | $1.55 | $98 |
| 2026-06-30 | 50 | $1.57 | $79 |
| 2026-06-26 | 1,161 | $1.51 | $1,753 |
| 2026-06-25 | 1,237 | $1.55 | $1,917 |
| 2026-06-24 | 211 | $1.50 | $317 |
| 2026-06-22 | 176 | $1.49 | $262 |
| 2026-06-17 | 730 | $1.48 | $1,080 |
| 2026-06-16 | 970 | $1.51 | $1,465 |
| 2026-06-15 | 1 | $1.51 | $2 |
| 2026-06-12 | 16,768 | $1.58 | $26,493 |
| 2026-06-09 | 69 | $1.54 | $106 |
| 2026-06-08 | 200 | $1.58 | $316 |
| 2026-06-03 | 539 | $1.52 | $819 |
| 2026-05-26 | 2,789 | $1.72 | $4,797 |
| 2026-05-22 | 74,322 | $1.73 | $128,577 |
| 2026-05-21 | 253,371 | $1.61 | $407,927 |
| 2026-05-20 | 1,137,456 | $1.60 | $1,819,930 |
Showing 1–18 of 18 settlements